United States · FDA National Drug Code directory
Enoxaparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-410_0f60383f-d466-4b5b-a501-62dda52eb3b7
- Product NDC
- 25021-410
- Form
- INJECTION
- Composition / generic term
- Enoxaparin Sodium
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231001
- Source listing expiry
- 20261231
Source-listed ingredients
- ENOXAPARIN SODIUM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (25021-410-70) / .3 mL in 1 SYRINGE · 25021-410-70
- 10 SYRINGE in 1 CARTON (25021-410-71) / 1 mL in 1 SYRINGE · 25021-410-71
- 10 SYRINGE in 1 CARTON (25021-410-76) / .4 mL in 1 SYRINGE · 25021-410-76
- 10 SYRINGE in 1 CARTON (25021-410-77) / .6 mL in 1 SYRINGE · 25021-410-77
- 10 SYRINGE in 1 CARTON (25021-410-78) / .8 mL in 1 SYRINGE · 25021-410-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →